Celldex Therapeutics, Inc. Stock Performance
as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
$24.02$25.02
2.00%
Downside
2.08%
Upside
52 Week's Low
52 Week's High
$14.4$4741.25%
Downside
91.76%
Upside
Celldex Therapeutics, Inc. share price movements today
- Previous Close
- $24.45
- Open
- $24.50
- Volume
- 1.2M
- Day's Low - High
- $24.02 - $25.02
- 52 Week Low - High
- $14.4 - $47
Celldex Therapeutics, Inc. Historical Returns
- 1 Month Return
- -4.12 %
- 3 Month Return
- + 15 %
- 1 Year Return
- -44.63 %
- 3 Year Return
- -19.33 %
- 5 Year Return
- + 108.44 %
Celldex Therapeutics, Inc. Stock Fundamentals & Key Indicators
Check Celldex Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.6B
EPS (TTM)
-3.4183
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-17.62
Industry PE ratio
10.127857142857144
P/B Ratio
0PEG Ratio
0EBITDA
-231.4M
Revenue (TTM)
5.8M
Profit Margin
0.00%
Return On Equity TTM
67460300.00%
Celldex Therapeutics, Inc. Stock Valuation
Track how Celldex Therapeutics, Inc. P/E has moved over time to understand its valuation trends.
Celldex Therapeutics, Inc. in the last 5 years
Lowest (0.00x)
September 15, 2025
Today (-17.62x)
September 15, 2025
Industry (10.13x)
September 15, 2025
Highest (0.00x)
September 15, 2025
Today’s Price to Earnings Ratio: -17.62x
Celldex Therapeutics, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Celldex Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.6B | 108.44% | -17.62 | 0.00% | |
| BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
| NA | $38.7B | NA | NA | -3.89% | |
| BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
| BUY | $59.4B | -3.43% | 14.11 | 31.37% |
Stock Returns calculator for Celldex Therapeutics, Inc. Stock including INR - Dollar returns
The Celldex Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Celldex Therapeutics, Inc. investment value today
Current value as on today
₹60,488
Returns
Returns from Celldex Therapeutics, Inc. Stock
Dollar Returns*
₹4,985 (+4.99%)
Analyst Recommendation on Celldex Therapeutics, Inc. Stock
Based on 14 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Celldex Therapeutics, Inc.. Average target price of $56.25
Celldex Therapeutics, Inc. Share Price Target
Get share price movements and forecasts by analysts on Celldex Therapeutics, Inc..
What analysts predicted
56.43%UPSIDE
Target Price
$56.25
Current Price
$24.51
Analyzed by
14 Analysts
Target
$56.25
Celldex Therapeutics, Inc. target price $56.25, a slight upside of 56.43% compared to current price of $24.51. According to 14 analysts rating.
Celldex Therapeutics, Inc. Stock's Interest Amongst Investors
Search interest for Celldex Therapeutics, Inc. Stock has increased by 371% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:371% versus previous 30 day period
Celldex Therapeutics, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Celldex Therapeutics, Inc. Annual Profit & Loss
All numbers in Millions USD
Celldex Therapeutics, Inc. Quarterly Cash Flow
All numbers in Millions USD
Celldex Therapeutics, Inc. Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. News & Key Events
Today's Timeline - 09 September
Tue, 06:31 PM
-Celldex Therapeutics to present at Morgan Stanley Healthcare Conference today at 3:20 PM ET.
Insights on Celldex Therapeutics, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, CLDX stock has moved up by 4.5%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 695.0K → 730.0K (in $), with an average increase of 4.8% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 142.8%
- NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 120.2%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 6 quarters, -32.80M → -56.6M (in $), with an average decrease of 11.6% per quarter
About Celldex Therapeutics, Inc.
| Organisation | Celldex Therapeutics, Inc. |
| Headquarters | Perryville III Building, Hampton, NJ, United States, 08827 |
| Industry | Health Technology |
| CEO | Mr. Anthony S. Marucci M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Celldex Therapeutics, Inc.
Name | Title |
|---|---|
Mr. Anthony S. Marucci M.B.A. | Founder, President, CEO & Director |
Dr. Tibor Keler Ph.D. | Founder, Chief Scientific Officer & Executive VP |
Mr. Sam Martin CPA | Senior VP, CFO, Secretary & Treasurer |
Ms. Sarah Cavanaugh | Senior Vice President of Corporate Affairs & Administration |
Mr. Freddy A. Jimenez Esq. | Senior VP & General Counsel |
Ms. Elizabeth Crowley | Chief Product Development Officer & Senior VP |
Dr. Margo Heath-Chiozzi M.D. | Senior Vice President of Regulatory Affairs |
Prof. Joseph P. Schlessinger Ph.D. | Co-Founder & Member of Scientific Advisory Board |
Dr. Ronald A. Pepin Ph.D. | Chief Business Officer & Senior VP |
Dr. Richard M. Wright Ph.D. | Chief Commercial Officer & Senior VP |
FAQs
What is Celldex Therapeutics, Inc. share price today?
Celldex Therapeutics, Inc. share price today is $24.51 as on at the close of the market. Celldex Therapeutics, Inc. share today touched a day high of $25.02 and a low of $24.02.
What is the 52 week high and 52 week low for Celldex Therapeutics, Inc. share?
Celldex Therapeutics, Inc. share touched a 52 week high of $47 on and a 52 week low of $14.4 on . Celldex Therapeutics, Inc. stock price today i.e. is closed at $24.51,which is 47.85% down from its 52 week high and 70.21% up from its 52 week low.
What is Celldex Therapeutics, Inc.'s market capitalisation today?
Celldex Therapeutics, Inc. market capitalisation is $0.00T as on .
How to invest in Celldex Therapeutics, Inc. Stock (CLDX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Celldex Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Celldex Therapeutics, Inc. Shares that will get you 0.0612 shares as per Celldex Therapeutics, Inc. share price of $24.51 per share as on September 16, 2025 at 1:29 am IST.
What is the minimum amount required to buy Celldex Therapeutics, Inc. Stock (CLDX) from India?
Indian investors can start investing in Celldex Therapeutics, Inc. (CLDX) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Celldex Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Celldex Therapeutics, Inc. share’s latest price of $24.51 as on September 16, 2025 at 1:29 am IST, you will get 0.4080 shares of Celldex Therapeutics, Inc.. Learn more about
fractional shares .
What are the returns that Celldex Therapeutics, Inc. has given to Indian investors in the last 5 years?
Celldex Therapeutics, Inc. stock has given 108.44% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?